The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Expected For The Next Generation Sequencing Market At The End Of The 2026–2030 Forecast Period?
The next generation sequencing market has expanded considerably in recent years. Its value is projected to increase from $14.2 billion in 2025 to $16.31 billion in 2026, reflecting a compound annual growth rate (CAGR) of 14.9%. This historical growth can be linked to factors such as intensified research efforts in genomics, the decreasing expenses of sequencing technologies, the expansion of molecular diagnostics laboratories, a heightened demand for genetic analysis linked to diseases, and the introduction of advanced sequencing reagents.
The next generation sequencing market is projected for significant expansion over the coming years, set to reach $28.59 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.1%. This anticipated growth throughout the forecast period stems from factors such as the increasing embrace of precision medicine initiatives, growing investments in population genomics research, the widening application of NGS in oncology diagnostics, a heightened demand for swift sequencing solutions, and the increased incorporation of sequencing data into clinical decision-making systems. Key trends anticipated during this period encompass the increasing uptake of high-throughput sequencing platforms, a surge in demand for clinical diagnostic sequencing, the evolving integration of AI-based bioinformatics tools, the broader expansion of targeted and personalized medicine applications, and a sharpened focus on cost-efficient sequencing workflows.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3990&type=smp
What Major Growth Drivers Are Shaping The Outlook Of The Next Generation Sequencing Market?
The next-generation sequencing market is projected to grow as the demand for personalized medicine increases. Personalized medicine, alternatively known as precision medicine, is an innovative approach in medical treatment and healthcare that considers an individual’s unique genetic, environmental, and lifestyle factors to customize medical decisions and treatments. Next-generation sequencing serves as a foundational technology for personalized medicine, facilitating the precise assessment of an individual’s genetic makeup and the development of tailored healthcare strategies. For instance, in February 2024, the Personalised Medicine Coalition, a US-based hospital and health care organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from 6 in 2022. Thus, the escalating demand for personalized medicine is a key driver for the growth of the next-generation sequencing market.
What Segment Types Make Up The Next Generation Sequencing Market?
The next generation sequencing market covered in this report is segmented –
1) By Product: Instruments, Reagents And Kits, Software
2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing, Other Sequencing Technologies
3) By Application: Diagnostics, Drug Discovery, Other Applications
Subsegments:
1) By Instruments: Sequencing Systems, Library Preparation Instruments, Quality Control Instruments
2) By Reagents And Kits: Sequencing Reagents, Library Preparation Kits, Amplification Kits
3) By Software: Data Analysis Software, Bioinformatics Software, Workflow Management Software
Which Market Trends Are Creating New Opportunities In The Next Generation Sequencing Market?
Leading companies in the next-generation sequencing market are prioritizing the development of advanced solutions like hybrid long- and short-read sequencing to improve genomic resolution and accuracy. This hybrid method combines the high throughput and low error rates of short reads with the structural insight and extensive coverage benefits of long reads. For instance, in March 2023, Illumina, a US-based biotechnology company, launched the Illumina Complete Long Read Prep, Human assay, featuring its innovative Complete Long Read technology. The assay enables the generation of both long- and short-read data on the same Illumina instrument and is specifically compatible with NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 systems. Its key characteristics include a simpler workflow with significantly reduced DNA input requirements compared to other long read platforms, the integration of Illumina sequencing-by-synthesis (SBS) chemistry with DRAGEN secondary analysis for highly accurate whole-genome sequencing, access to hard to map, challenging genic regions, and a promotional price of US $1,350 per genome (on NovaSeq X Plus with a 25B flow cell), which includes long- and short-read library preparation, sequencing, and cloud analysis.
Who Are The Key Players Driving Competition In The Next Generation Sequencing Market?
Major companies operating in the next generation sequencing market are Illumina Inc, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Oxford Nanopore Technologies Ltd, QIAGEN NV, Agilent Technologies Inc, PerkinElmer Inc, BGI Group, 10x Genomics Inc, Takara Bio Inc, New England Biolabs Inc, Twist Bioscience Corp, Element Biosciences Inc, Ultima Genomics Inc, SeqWell Inc, Integrated DNA Technologies Inc, LGC Limited, Bio-Rad Laboratories Inc, Zymo Research Corporation, NimaGen BV
Read the full next generation sequencing market report here:
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report
Which Regions Are Projected To Dominate The Next Generation Sequencing Market In The Coming Years?
North America was the largest region in the next generation sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next generation sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Next Generation Sequencing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3990&type=smp
Browse Through More Reports Similar to the Global Next Generation Sequencing Market 2026, By The Business Research Company
Clinical Oncology Next Generation Sequencing Market Report 2026
Clinical Next Generation Sequencing Ngs Data Analysis Market Report 2026
Dna Sequencing Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model